Opening book details…
About this Medicine article
A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149) by H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. Seymour is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. Seymour
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
- Published
- 2010
- Field
- Medicine (Health Sciences)